You are here

  • Home
  • Archive
  • Volume 27, Issue 9
  • Veliparib Monotherapy to Patients With BRCA Germ Line Mutation and Platinum-Resistant or Partially Platinum-Sensitive Relapse of Epithelial Ovarian Cancer: A Phase I/II Study

Article metrics

Article menu
Download PDFPDF
Ovarian Cancer
Veliparib Monotherapy to Patients With BRCA Germ Line Mutation and Platinum-Resistant or Partially Platinum-Sensitive Relapse of Epithelial Ovarian Cancer: A Phase I/II Study

 

Online download statistics by month:

Online download statistics by month: February 2019 to April 2024

AbstractFullPdf
Feb 2019600
Mar 20194400
Apr 20193101
May 20195700
Jun 20197600
Jul 201911003
Aug 20193701
Sep 20193901
Oct 20195602
Nov 20193402
Dec 20192202
Jan 20202901
Feb 20203303
Mar 20203506
Apr 20204401
May 20205701
Jun 20204201
Jul 202058010
Aug 20202202
Sep 20205004
Oct 20201801
Nov 20203505
Dec 20203001
Jan 20213403
Feb 20214900
Mar 20211100
Apr 20216003
May 20211802
Jun 2021003
Jul 2021302
Aug 2021104
Sep 2021002
Oct 20212902
Nov 20212802
Dec 20213100
Jan 20225202
Feb 20222400
Mar 20226201
Apr 20224602
May 20224602
Jun 20228102
Jul 20223900
Aug 20226302
Sep 20226200
Oct 20227400
Nov 20223501
Dec 20224301
Jan 20232701
Feb 20238701
Mar 20234102
Apr 20232600
May 20232800
Jun 20234302
Jul 20232000
Aug 20231801
Sep 20232100
Oct 202311905
Nov 20233600
Dec 20238400
Jan 20245000
Feb 20244402
Mar 20245801
Apr 20243601
Total25940100